Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RN624 (Tanezumab) in Chronic Low Back Pain
NCT00584870Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2007
- Primary completion
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tanezumab in chronic low back pain (CLBP), sponsored by Pfizer. Started Jul 2007; status: completed.
02
Drugs
tanezumab
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00584870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584870.